Inst Diagnosti (INDISA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Inst Diagnosti (INDISA) has a cash flow conversion efficiency ratio of 0.087x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CL$8.87 Billion ≈ $9.92 Million USD) by net assets (CL$102.41 Billion ≈ $114.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Inst Diagnosti for the company's overall valuation and market capitalisation.
Inst Diagnosti - Cash Flow Conversion Efficiency Trend (2014–2021)
This chart illustrates how Inst Diagnosti's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Inst Diagnosti Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Inst Diagnosti ranked by their cash flow conversion efficiency. Explore Inst Diagnosti cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gladstone Capital Corporation
NASDAQ:GLAD
|
-0.102x |
|
Colony Bankcorp Inc.
NYSE:CBAN
|
0.023x |
|
Linc AB
ST:LINC
|
-0.001x |
|
Doubledown Interactive Co Ltd
NASDAQ:DDI
|
0.044x |
|
PetroVietnam Transportation Corp
VN:PVT
|
0.088x |
|
Tianjin Binhai Energy & Development Co Ltd
SHE:000695
|
-0.074x |
|
Shenmao Technology Inc
TW:3305
|
-0.048x |
|
Good Finance Securities Co Ltd
TWO:6021
|
-0.047x |
Annual Cash Flow Conversion Efficiency for Inst Diagnosti (2014–2021)
The table below shows the annual cash flow conversion efficiency of Inst Diagnosti from 2014 to 2021. View INDISA live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2021-12-31 | CL$95.17 Billion ≈ $106.43 Million |
CL$14.83 Billion ≈ $16.59 Million |
0.156x | -8.57% |
| 2020-12-31 | CL$84.82 Billion ≈ $94.86 Million |
CL$14.46 Billion ≈ $16.17 Million |
0.170x | +30.98% |
| 2019-12-31 | CL$81.92 Billion ≈ $91.61 Million |
CL$10.66 Billion ≈ $11.92 Million |
0.130x | -32.89% |
| 2018-12-31 | CL$76.08 Billion ≈ $85.09 Million |
CL$14.75 Billion ≈ $16.50 Million |
0.194x | -10.15% |
| 2017-12-31 | CL$69.00 Billion ≈ $77.16 Million |
CL$14.89 Billion ≈ $16.65 Million |
0.216x | +17.62% |
| 2016-12-31 | CL$63.05 Billion ≈ $70.51 Million |
CL$11.57 Billion ≈ $12.94 Million |
0.183x | -30.86% |
| 2015-12-31 | CL$56.73 Billion ≈ $63.44 Million |
CL$15.05 Billion ≈ $16.84 Million |
0.265x | -2.00% |
| 2014-12-31 | CL$50.16 Billion ≈ $56.10 Million |
CL$13.58 Billion ≈ $15.19 Million |
0.271x | -- |
About Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more